Active Clinical Research for Solid Tumors

Comprehensive Cancer Centers is currently running the following Phase II and Phase III clinical research studies for solid tumors:

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial
Study#: i2716
Contact Us: For information about this clinical study, Email Us.

A Phase 2, Open-Label, Multicenter, Tumor-agnostic Study of MK-1084 as Monotherapy and in Combination with Cetuximab in Participants with KRAS G12C Mutant, Advanced Solid Tumors (KANDLELIT-014).
Study#: Pending
Contact Us: For information about this clinical study, Email Us.